IK
Isabel Kalofonos (Chief Commercial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Crinetics Pharmaceuticals, Inc. (CRNX). The largest single filing was $138K of CRNX (2,500 sh × $55.00, as filed), executed Jan 5. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$138K
shares × price, as filed
Last traded
Jan 5
Filed Jan 7
Median ADV $326.9M across their filed names
Open performance→Volume by month
Buys $0
Sells $138K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
CRNXRecent filings
CRNXSALE
Crinetics Pharmaceuticals, Inc.
View filing →
$138K2,500 sh × $55.00
Exec Jan 5
Filed Jan 7 · 5:30 PM ET